• share
• favorite_border

Oncology community professionals are concerned about the ability of their patients to access cancer screening and treatment under the proposed American Health Care Act, according to a survey conducted March 23–25, 2017 at the National Comprehensive Cancer Network® (NCCN®) 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ at the Rosen Shingle Creek in Orlando, Florida.

• share
• favorite_border

University of Colorado Cancer Center Study uncovers discrepant decision-making for use of 21-gene assay in women with cancer: • Testing occurs in high-risk population, despite current evidence • Non-concordance with NCCN Guidelines® recommendations • Racial and socio-economic disparities found in testing use

• share
• favorite_border

NCCN Imaging AUC™ provide a single access point for all oncology imaging recommendations within the NCCN Guidelines®; currently, NCCN Imaging AUC™ are available for 48 NCCN Guidelines.

• share
• favorite_border

More than 1,600 oncology professionals attended the NCCN 22nd Annual Conference in Orlando, Florida

• share
• favorite_border

In the first time addressing a public forum together, Kalanithi’s widow, Lucy Kalanithi, MD, Clinical Assistant Professor of Medicine at Stanford School of Medicine; and Paul’s treating oncologist, Heather Wakelee, MD, Associate Professor of Medicine at Stanford Cancer Institute, spoke about their experiences on March 24, 2017 during the National Comprehensive Cancer Network® (NCCN®) 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™.

• share
• favorite_border

NCCN Conference Roundtable Addresses Health Disparities

• share
• favorite_border

NCCN Foundation Young Investigator Awards provide grants of $150,000 over a two-year period for research initiatives focused on assessing and improving outcomes in cancer care.

• share
• favorite_border

Gena Cook, Co-Founder and Chief Executive Officer, Navigating Cancer, and Heather Kopecky, PhD, MBA, Senior Client Partner, Korn Ferry, have been named Chair and Vice-Chair, respectively, of the NCCN Foundation Board of Directors.

• share
• favorite_border

Launched during the NCCN 22nd Annual Conference, the new NCCN Radiation Therapy Compendium™ provides a single access point for radiation therapy recommendations within the NCCN Guidelines®.

• share
• favorite_border

New NCCN Guidelines for Patients®: Distress available on NCCN.org/patients

• share
• favorite_border

Researchers at Yale Cancer Center/Smilow Cancer Hospital found that black and Hispanic women in Connecticut are significantly less likely to undergo gene expression profiling than white women.

• share
• favorite_border

22nd Annual Conference is March 23–25, 2017, in Orlando, FL

• share
• favorite_border

The NCCN Oncology Research Program has awarded grants for its first-ever multi-industry collaborative project, soliciting investigator-initiated proposals to research the effectiveness of Boehringer Ingelheim’s afatinib in combination with other drugs to treat lung and head and neck cancers.

• share
• favorite_border

The National Comprehensive Cancer Network® (NCCN®), through funding from the NCCN Foundation® and Kidney Cancer Association, has published a German translation of the NCCN Guidelines for Patients®: Kidney Cancer.

• share
• favorite_border

A recent study from the UCSF Center for Translational and Policy Research on Personalized Medicine and the UCSF Helen Diller Family Comprehensive Cancer Center identified opportunities to address the barriers to coverage of hereditary cancer panels, as published in JNCCN.

• share
• favorite_border

NCCN has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ sheet for Waldenström’s Macroglobulinemia—a rare, but manageable type of Non-Hodgkin’s Lymphoma.

• share
• favorite_border

NCCN’s second policy and advocacy fellow will maintain a comprehensive understanding of the oncology policy landscape, contribute to the advancement of NCCN’s policy initiatives, and contribute to the monitoring and awareness of use of NCCN Content by public and private payers to enhance access to and delivery of quality oncology care in the United States.

• share
• favorite_border

NCCN has published NCCN Guidelines for Patients®: Brain Cancer – Gliomas, available today on NCCN.org/patients and NCCN Patient Guides for Cancer mobile app

• share
• favorite_border

NCCN will host its annual patient advocacy summit on December 9 in Washington, DC to explore gaps in current value tools, as well as patient definitions of value.

• share
• favorite_border

NCCN Imaging AUC™ provide a single access point for all oncology imaging recommendations within the NCCN Guidelines®; currently, NCCN Imaging AUC™ are available for 35 NCCN Guidelines.

• share
• favorite_border

NCCN has published NCCN Guidelines for Patients®: Nausea and Vomiting, available on NCCN’s new mobile app for patients.

• share
• favorite_border

As reported in JNCCN, a recent study from McGill University shows that while opioid use increases during treatment in older patients with breast cancer, most do not continue use into survivorship; however, use of anxiolytics and antidepressants remains high in survivors.

• share
• favorite_border

Providing access to NCCN Templates® through Cerner’s PowerChart Oncology™ will help practitioners make informed treatment decisions based on up-to-date, standard protocols

• share
• favorite_border

As published in JNCCN, a recent project out of Canada shows that programs identifying stress and distress in patients with cancer increase health care professionals’ confidence and awareness of patient-centeredness; outcomes are influenced by site-based navigators and practice size.

• share
• favorite_border

NCCN has published new patient education materials for Stomach Cancer; these resources are available to download free of charge at NCCN.org/patients.

• share
• favorite_border

The NCCN 11th Annual Congress: Hematologic Malignancies™ returns to New York City September 30 – October 1, 2016; registration is still open at NCCN.org/HEM

• share
• favorite_border

New NCCN Guidelines for Myeloproliferative Neoplasms focus on the treatment of Myelofibrosis, a rare bone marrow cancer; the new recommendations are the most comprehensive treatment guidance available to U.S. clinicians today.

• share
• favorite_border

Integration of NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) into New Century Health’s clinical decision support platform will expand national use of evidence-based imaging recommendations adapted from the NCCN Guidelines®.

• share
• favorite_border

As published in JNCCN, a new Brown University study of registry data for older patients with diffuse large B-cell lymphoma treated with contemporary immunochemotherapy found opportunities to mitigate early death using key risk factors in decision-making and providing prophylactic administration of G-CSF; additional studies are warranted.

• share
• favorite_border

The NCCN Oncology Research Program has awarded research grants to three investigators to study bavituximab in glioblastoma, head and neck cancer, and hepatocellular carcinoma.

• share
• favorite_border

NCCN Imaging AUC™ provide a single access point for all oncology imaging recommendations within the NCCN Guidelines; currently, NCCN Imaging AUC™ are available for 20 cancer types.

• share
• favorite_border

Integration of NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) into MedCurrent’s OrderWise™ platform will provide access to evidence-based imaging recommendations adapted from the NCCN Guidelines®.

• share
• favorite_border

As published in JNCCN, researchers at The University of Texas MD Anderson Cancer Center found that, at the state level, wealth—not health expenditure—is a determinant for better outcomes in most cancers.

• share
• favorite_border

Integration of NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) into NDSC CareSelect Imaging will provide access to evidence-based imaging recommendations adapted from the NCCN Guidelines®.

• share
• favorite_border

A Medical College of Wisconsin study published in the July issue of JNCCN found that older women are not receiving recommended bone density assessment prior to adjuvant therapy with aromatase inhibitors, possibly making them more vulnerable to bone fracture and comorbidity as a result of injury.

• share
• favorite_border

NCCN joins 10 other multidisciplinary organizations as a qualified provider-led entity under the Medicare Appropriate Use Criteria (AUC) program for advanced diagnostic imaging.

• share
• favorite_border

New NCCN Guidelines for Patients® and NCCN Quick Guide™ series outline disease basics, testing, and treatment information about MDS so patients can make well-informed decisions about their cancer care.

• share
• favorite_border

NCCN Policy Summit to Address the State of HIT June 27 in Washington, D.C.

• share
• favorite_border

New NCCN Guidelines for Patients® and NCCN Quick Guide™ outline disease basics, testing, and treatment information about Mycosis Fungoides so patients can make well-informed decisions about their cancer care.

• share
• favorite_border

A new study published today on JNCCN.org suggests that severe anxiety at end of life in patients with cancer is caused not solely by proximity to death, but by disease burden and psychosocial issues.

• share
• favorite_border

The NCCN Oncology Research Program has awarded research grants to eight investigators to study the effectiveness of mirvetuximab soravtansine in folate receptor alpha-positive cancers.

• share
• favorite_border

New NCCN Imaging Appropriate Use Criteria Compendium provides a single access point for all imaging recommendations within the NCCN Guidelines

• share
• favorite_border

Through funding from EMD Serono, NCCN is instituting a Policy and Advocacy Fellowship designed for implementation of policy programs that will enhance access to and delivery of quality oncology care in the United States and globally.

• share
• favorite_border

NCCN has published new patient education materials for Diffuse Large B-Cell, Follicular, Mantle Cell, and Peripheral T-Cell Lymphomas; these resources are available for download free of charge at NCCN.org/patients and print versions may be ordered through Amazon.com.

• share
• favorite_border

Representatives from American Cancer Society, National Comprehensive Cancer Network (NCCN), and U.S. Preventive Services Task Force deliberated recent controversies in breast cancer screening recommendations.

• share
• favorite_border

On Saturday, April 2, 2016, during the NCCN 21st Annual Conference, Judith Paice, PhD, RN, FAAN, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discussed best practices in management of chronic pain in people with cancer.

• share
• favorite_border

More than 1,600 oncology professionals attended the NCCN 21st Annual Conference, which featured presentations of the latest developments in the treatment of more than 15 cancer types, as well as expert roundtables and panel discussions.

• share
• favorite_border

The second roundtable discussion of the NCCN 21st Annual Conference had pundits from both sides of the aisle discuss the stakes in an election year for people with cancer

• share
• favorite_border

The NCCN 21st Annual Conference kicked off with a look into the world of palliative care, exploring barriers to patient access and means to establish multidisciplinary palliative care teams.

• share
• favorite_border

Timothy J. Eberlein, MD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, has been elected Chairman of the NCCN Board of Directors, succeeding Samuel M. Silver, MD, PhD, University of Michigan Comprehensive Cancer Center.